← Back to Clinical Trials
Recruiting NCT07384585

NCT07384585 Feasibility of Light Therapy in the Pediatric Intensive Care Unit (ICU)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07384585
Status Recruiting
Phase
Sponsor Laura Beth Kalvas
Condition Circadian Dysregulation
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2026-03
Primary Completion 2027-01

Trial Parameters

Condition Circadian Dysregulation
Sponsor Laura Beth Kalvas
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 4 Years
Max Age 17 Years
Start Date 2026-03
Completion 2027-01
Interventions
Light Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to understand how easy or difficult it is for critically ill children (4-17 years old) to have light therapy while in the pediatric ICU. Participants will have a light meter at their bedside to measure light levels. Each morning, a light box will be placed at their bedside. Children, family, and staff will be asked to completed feedback surveys regarding the light therapy. Study participation will continue for a maximum of 5 days.

Eligibility Criteria

Inclusion Criteria: * Anticipated to remain admitted to the study hospital pediatric ICU for additional 48 hours * English-speaking parent/legally authorized representative available at the bedside Exclusion Criteria: * Patients unable to open their eyes to receive light therapy (Glasgow Coma Scale eye opening score of 1 or neuromuscular blockade) * Patients with contraindications to light therapy (e.g., migraines, retinal disease, diseases associated with retinal complications, blindness, bipolar disorder, seizure disorder, traumatic brain injury) * Suspected/identified neglect/abuse, Child Protective Services involvement, or ward of state * Children receiving palliative/end-of-life care * Unable to fit light box/cart in patient room

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology